Bakx, Jeanne A.C.

Bijlsma, Maarten F.

Doeve, Benthe H.

Rosman, Camiel

Siersema, Peter D.

van Berge Henegouwen, Mark I.

van Grieken, Nicole C.T.

van Laarhoven, Hanneke W.M.

van Sandick, Johanna W.

Verheij, Marcel

Verhoeven, Rob H.A.

English

Background: The COVID-19 pandemic has affected the entire global healthcare system, including oncological care. This study investigated the effects of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer in the Netherlands. Methods: Patients diagnosed in 2020 were divided into 5 periods, based on the severity of the COVID-19 pandemic in the Netherlands, and compared to patients diagnosed in the same period in the years 2017–2019. Patient characteristics and treatments were evaluated for esophageal cancer (EC) and gastric cancer (GC) separately. Results: The number of esophagogastric cancer diagnoses decreased prominently during the first 2 months of the COVID-19 pandemic. During this period, a significantly higher percentage of GC patients was diagnosed with incurable disease (52.5% in 2017–2019 and 67.7% in 2020, p = 0.011). We observed a significant reduction in the percentage of patients with potentially curable EC treated with resection and neoadjuvant chemoradiotherapy (from 35.0% in 2017–2019 to 27.3% in 2020, p &lt; 0.001). Also, patients diagnosed with incurable GC were treated less frequently with a resection (from 4.6% in 2017–2019 to 1.5% in 2020, p = 0.009) in the second half of 2020. Conclusions:Compared to previous years, the number of esophagogastric cancer diagnoses decreased in the first 2 months of the COVID-19 pandemic, while an increased percentage of patients was diagnosed with incurable disease. Both in the curative and palliative setting, patients were less likely to be treated with a surgical resection.</p

EUR Research Repository

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer

Benthe H. Doeve

Jeanne A. C. Bakx

Peter D. Siersema

Camiel Rosman

Nicole C. T. van Grieken

Mark I. van Berge Henegouwen

Johanna W. van Sandick

Marcel Verheij

Maarten F. Bijlsma

Rob H. A. Verhoeven

Hanneke W. M. van Laarhoven

Crossref

https://pure.eur.nl/files/98459838/The_impact_of_the_COVID-19_pandemic_on_the_diagnosis_stage_and_treatment_of_esophagogastric_cancer.pdf

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer

Abstract

Similar works

Full text

Available Versions

EUR Research Repository

EUR Research Repository

Crossref